mepivacaine has been researched along with Kidney Failure, Chronic in 5 studies
Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with end-stage chronic renal failure are at risk of developing several serious postanaesthetic complications." | 2.70 | High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study. ( Alvarez, J; Bárcena, M; Diz, C; López-Rivadulla, M; Quintela, O; Rodríguez, J, 2001) |
"Hereby, ESRD patients can be treated without general anesthesia, while ensuring functionality of the PD catheter." | 1.62 | Implantation of a peritoneal dialysis catheter in patients with ESRD using local anesthesia and Remifentanil. ( Fütterer, C; Jabbour, E; Kälsch, AI; Keese, M; Krämer, BK; Rahbari, NN; Schwenke, KG; Zach, S, 2021) |
" Few reports of systemic adverse effects are available following nerve blockade with mepivacaine." | 1.33 | [Systemic toxicity with mepivacaine following axillary block in a patient with terminal kidney failure]. ( Cuvillon, P; Ripart, J; Tanoubi, I; Vialles, N, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Jabbour, E | 1 |
Fütterer, C | 1 |
Zach, S | 1 |
Kälsch, AI | 1 |
Keese, M | 1 |
Rahbari, NN | 1 |
Krämer, BK | 1 |
Schwenke, KG | 1 |
Mojica, V | 1 |
Nieuwveld, D | 1 |
Herrera, AE | 1 |
Mestres, G | 1 |
López, AM | 1 |
Sala-Blanch, X | 1 |
Soto Mesa, D | 1 |
Bermejo Álvarez, MA | 1 |
García Menéndez, MJ | 1 |
Fayad Fayad, M | 1 |
Tanoubi, I | 1 |
Vialles, N | 1 |
Cuvillon, P | 1 |
Ripart, J | 1 |
Rodríguez, J | 1 |
Quintela, O | 1 |
López-Rivadulla, M | 1 |
Bárcena, M | 1 |
Diz, C | 1 |
Alvarez, J | 1 |
1 trial available for mepivacaine and Kidney Failure, Chronic
Article | Year |
---|---|
High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study.
Topics: Aged; Anesthetics, Local; Brachial Plexus; Female; Humans; Kidney Failure, Chronic; Male; Mepivacain | 2001 |
4 other studies available for mepivacaine and Kidney Failure, Chronic
Article | Year |
---|---|
Implantation of a peritoneal dialysis catheter in patients with ESRD using local anesthesia and Remifentanil.
Topics: Adult; Aged; Aged, 80 and over; Catheterization; Feasibility Studies; Female; Humans; Kidney Failure | 2021 |
Axillary brachial plexus block duration with mepivacaine in patients with chronic renal failure. Case-control study.
Topics: Anesthetics, Local; Arteriovenous Shunt, Surgical; Axilla; Brachial Plexus Block; Case-Control Studi | 2017 |
[Axillary brachial plexus block in a patient with Bardet-Biedl syndrome].
Topics: Adult; Airway Management; Airway Obstruction; Anesthesia, General; Anesthetics, Local; Axilla; Barde | 2012 |
[Systemic toxicity with mepivacaine following axillary block in a patient with terminal kidney failure].
Topics: Anesthetics, Local; Arteriovenous Shunt, Surgical; Confusion; Dysarthria; Humans; Kidney Failure, Ch | 2006 |